Management of refractory early-stage cutaneous T-cell lymphoma (mycosis fungoides) with a combination of oral bexarotene and psoralen plus ultraviolet bath therapy.
Margit A
MA
Huber
Karin
K
Kunzi-Rapp
Gyde
G
Staib
Karin
K
Scharffetter-Kochanek
D000284:Administration, Oral; D000368:Aged; D016588:Anticarcinogenic Agents / Q000008:administration & dosage*; D000077610:Bexarotene; D004359:Drug Therapy, Combination; D005363:Ficusin / Q000008:administration & dosage*; D006801:Humans; D008297:Male; D009182:Mycosis Fungoides / Q000188:drug therapy*; D013764:Tetrahydronaphthalenes / Q000008:administration & dosage*; D014467:Ultraviolet Therapy / Q000379:methods*
D016588:Anticarcinogenic Agents; D013764:Tetrahydronaphthalenes; D000077610:Bexarotene; D005363:Ficusin